Results 91 to 100 of about 224,706 (187)

Evaluation of the Graves’ Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population

Journal of Ophthalmology, 2019
Purpose. To study the clinical significance of the Graves’ orbitopathy-specific quality of life (GO-QOL) questionnaire in mainland Chinese patients. Methods.
Peng Zeng, Shu-xian Fan, Zi-jing Li, Yuan-yu Peng, Yu-xin Hu, Ming-tong Xu, Mei Wang   +6 more
doaj   +1 more source

The clinical tomographic interconnection in diplopia of patients with Graves' orbitopathy

Клиническая и экспериментальная тиреоидология, 2012
There was investigated the relationship between the clinical features of the diplopia in patients with the Graves’ orbitopathy and the specific signs of the orbit obtained by the multi-slice CT scanning in the study.

doaj   +1 more source

Optimal management of Graves orbitopathy: a multidisciplinary approach

, 2011
Graves' thyroid disease is a relatively common disorder in endocrinology and general internal medicine practice. Graves' hyperthyroidism is mediated by circulating stimulating autoantibodies.
van Zeijl, C. J. J., Kloos, R., Boelen, A., Soeters, M. R., Mourits, M. P., Vriesendorp, T. M., Saeed, P.   +6 more
core  

Impact of Graves' orbitopathy on quality of life

, 2014
Objective. This study was conducted to assess the impact of Graves' orbitopathy on the quality of life in our population by using disease-specific questionnaire (GO-QOL) recommended by the European Group on Graves' Orbitopathy (EUGOGO). Methods.
Bubanja D., Ćirić J., Bubanja I., Sulubiric D.   +3 more
core   +1 more source

Case series of dermopathy in autoimmune thyroid disease [PDF]

Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"
Graves' disease (GD) is an autoimmune disease that can affect other tissues in addition to the thyroid gland. The clinical manifestations are a result of the impact of TSH receptor antibodies.
Janić Tamara, Stojković Mirjana, Marković Bojan, Đurković Ivana, Babić Jovana, Joksimović Nata, Nedeljković-Beleslin Biljana, Ćirić Jasmina, Žarković Miloš   +8 more
doaj   +1 more source

Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.

, 2020
PURPOSE: Patients with Graves' orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves' orbitopathy. METHODS: This was a multi-centre
Boschi, Antonella, Pitz, Susanne, Dayan, Colin M, Menconi, Francesca, Morris, Daniel S, Pearce, Simon H, Hegedüs, László, Leo, Marenza, Clarke, Lucy, Muller, Ilaria, Mathiopoulou, Lemonia, Currò, Nicola, Marcocci, Claudio, Azzolini, Claudio, Brix, Thomas H, Nardi, Marco, Bernard, Martine, Ẑarković, Miloš P, Daumerie, Chantal, Fichter, Nicole, European Group on Graves’ Orbitopathy, Covelli, Danila, Ćirić, Slavica, Salvi, Mario, Möller, Lars, Panagiotou, Grigorios C, Törüner, Füsun, Perros, Petros, Ayvaz, Göksun, Baldeschi, Lelio, Bartalena, Luigi, Knežević, Miroslav, Konuk, Onur, Orgiazzi, Jacques, Marinò, Michele, Kahaly, Georges J, Okosieme, Onyebuchi E, Lareida, Jürg J, Eckstein, Anja K, Wiersinga, Wilmar M   +39 more
core   +1 more source

Orbital decompression in Graves` orbitopathy

Medicinski pregled, 2012
Introduction. This paper was aimed at presenting our experience and results in the surgical management for proptosis in patients with Graves` orbitopathy. Material and Methods. This is a retrospective, interventional, non-comparative case series review.
Miroslav, Knezević, Branislav, Stanković, Dejan M, Rasić, Milos, Zarković, Jasmina, Cirić, Biljana, Beleslin   +5 more
openaire   +3 more sources

TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy

Archives of Endocrinology and Metabolism
Objective Thyrotoxicosis is established risk factor for osteoporosis due to increased bone turnover. Glucocorticoids often administered for Graves' orbitopathy (GO) have additional negative effect on bone mineral density (BMD). Our aim was to examine the
Mira Siderova, Kiril Hristozov, Aleksandra Tsukeva   +2 more
doaj   +1 more source

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities

, 2016
Statins use has been associated with reduced risk for developing orbitopathy among patients with Graves’ disease. We hypothesize that statin reduces orbitopathy risk mainly by modulating both apoptosis and autophagy activities in patients with Graves ...
Ciaglia Elena, CIAGLIA, ELENA, Bifulco Maurizio, BIFULCO, Maurizio   +3 more
core   +1 more source